Mitophagy in neurodegeneration and aging. 2012

Konstantinos Palikaras, and Nektarios Tavernarakis
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas, Heraklion Crete, Greece.

Macroautophagy is a cellular catabolic process that involves the sequestration of cytoplasmic constituents into double-membrane vesicles known as autophagosomes, which subsequently fuse with lysosomes, where they deliver their cargo for degradation. The main physiological role of autophagy is to recycle intracellular components, under conditions of nutrient deprivation, so as to supply cells with vital materials and energy. Selective autophagy also takes place in nutrient-rich conditions to rid the cell of damaged organelles or protein aggregates that would otherwise compromise cell viability. Mitophagy is a selective type of autophagy, whereby damaged or superfluous mitochondria are eliminated to maintain proper mitochondrial numbers and quality control. While mitophagy shares key regulatory factors with the general macroautophagy pathway, it also involves distinct steps, specific for mitochondrial elimination. Recent findings indicate that parkin and the phosphatase and tensin homolog-induced putative kinase protein 1 (PINK1), which have been implicated in the pathogenesis of neurodegenerative diseases such as Parkinson's disease, also regulate mitophagy and function to maintain mitochondrial homeostasis. Here, we survey the molecular mechanisms that govern the process of mitophagy and discuss its involvement in the onset and progression of neurodegenerative diseases during aging.

UI MeSH Term Description Entries

Related Publications

Konstantinos Palikaras, and Nektarios Tavernarakis
October 2017, Neurochemistry international,
Konstantinos Palikaras, and Nektarios Tavernarakis
October 2022, The journal of cardiovascular aging,
Konstantinos Palikaras, and Nektarios Tavernarakis
January 2023, Frontiers in neuroscience,
Konstantinos Palikaras, and Nektarios Tavernarakis
April 2022, IUBMB life,
Konstantinos Palikaras, and Nektarios Tavernarakis
November 2013, Autophagy,
Konstantinos Palikaras, and Nektarios Tavernarakis
June 2011, Current drug targets,
Konstantinos Palikaras, and Nektarios Tavernarakis
July 2023, Cells,
Konstantinos Palikaras, and Nektarios Tavernarakis
January 2020, Frontiers in cell and developmental biology,
Konstantinos Palikaras, and Nektarios Tavernarakis
January 2022, Neurochemistry international,
Copied contents to your clipboard!